Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Risk, clinical course and outcome of ischemic stroke in patients hospitalized with COVID-19: a multicenter cohort study

Wouter M. Sluis, Marijke Linschoten, Julie E. Buijs, J. Matthijs Biesbroek, Heleen M. den Hertog, Tessa Ribbers, Dennis Nieuwkamp, Reinier C. van Houwelingen, Andreas Dias, Ingeborg W.M. van Uden, Joost P. Kerklaan, H. Paul Bienfait, Sarah E. Vermeer, Sonja W. de Jong, Mariam Ali, Marieke J.H. Wermer, Marieke T. de Graaf, Paul J.A.M. Brouwers, Folkert W. Asselbergs, L. Jaap Kappelle, H. Bart van der Worp, Annemijn M. Algra
doi: https://doi.org/10.1101/2021.03.11.21253189
Wouter M. Sluis
1Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marijke Linschoten
2Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie E. Buijs
3Department of Neurology, Spaarne Gasthuis, Haarlem/Hoofddorp, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Matthijs Biesbroek
4Department of Neurology, Diakonessenhuis Hospital, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heleen M. den Hertog
5Department of Neurology, Isala Hospital, Zwolle, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tessa Ribbers
6Department of Neurology, Jeroen Bosch Hospital, ‘s Hertogenbosch, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis Nieuwkamp
6Department of Neurology, Jeroen Bosch Hospital, ‘s Hertogenbosch, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reinier C. van Houwelingen
7Department of Neurology, Treant Hospital, Emmen, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Dias
8Department of Neurology, Ikazia Hospital, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingeborg W.M. van Uden
9Department of Neurology, Catharina Hospital, Eindhoven, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joost P. Kerklaan
10Department of Neurology, St. Antonius Hospital, Nieuwegein, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Paul Bienfait
11Department of Neurology, Gelre Hospital, Apeldoorn, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah E. Vermeer
12Department of Neurology, Rijnstate Hospital, Arnhem, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonja W. de Jong
13Department of Neurology, St. Jansdal Hospital, Harderwijk, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariam Ali
14Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marieke J.H. Wermer
15Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marieke T. de Graaf
16Department of Neurology, Zaans Medisch Centrum, Zaandam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul J.A.M. Brouwers
17Department of Neurology, Medisch Spectrum Twente, Enschede, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Folkert W. Asselbergs
2Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
18Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, United Kingdom
19Health Data Research UK and Institute of Health Informatics, University College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Jaap Kappelle
1Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Bart van der Worp
1Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annemijn M. Algra
1Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: a.m.algra-3@umcutrecht.nl
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background and purpose The frequency of ischemic stroke in patients with COVID-19 varies in the current literature, and risk factors are unknown. We assessed the incidence, risk factors, and outcomes of acute ischemic stroke in hospitalized patients with COVID-19.

Methods We included patients with a laboratory confirmed SARS-CoV-2 infection admitted in 16 hospitals participating in the international CAPACITY-COVID registry between March 1st and August 1st, 2020. Patients were screened for the occurrence of acute ischemic stroke. We calculated the cumulative incidence of ischemic stroke and compared risk factors, cardiovascular complications, and in-hospital mortality in patients with and without ischemic stroke.

Results We included 2147 patients with COVID-19, of whom 586 (27.3%) needed treatment at an intensive care unit (ICU). Thirty-eight patients (1.8%) had an ischemic stroke. Patients with stroke were older, but did not differ in sex or cardiovascular risk factors. Median time between onset of COVID-19 symptoms and diagnosis of stroke was two weeks. The incidence of ischemic stroke was higher among patients who were treated at an ICU (16/586; 2.7% versus 22/1561; 1.4%; p=0.039). Pulmonary embolism was more common in patients with (8/38; 21.1%) than in those without stroke (160/2109; 7.6%; adjusted RR: 2.08; 95%CI:1.52-2.84). Twenty-seven patients with ischemic stroke (71.1%) died during admission or were functional dependent at discharge and in-hospital mortality. Patients with ischemic stroke were at a higher risk of in-hospital mortality (adjusted RR 1.56; 95%CI:1.13-2.15) than patients without stroke.

Conclusions In this multicenter cohort study, the cumulative incidence of acute ischemic stroke in hospitalized patients with COVID-19 was approximately 2%, with a higher risk in patients treated at an ICU. The majority of stroke patients had a poor outcome. The association between ischemic stroke and pulmonary embolism warrants further investigation.

Competing Interest Statement

Wouter M. Sluis is supported by the European Unions Horizon, 2020 research and innovation programme (grant no. 634809). Marijke Linschoten is supported by the Alexandre Suerman Stipend of the University Medical Center Utrecht. J.P. Kerklaan participates in the PACIFIC-stroke trial. Folkert W. Asselbergs is supported by University College London Hospitals National Institute for Health Research Biomedical Research and CardioVasculair Onderzoek Nederland 2015-12 eDETECT. M.J.H Wermer is supported by a personal grant from the Dutch Heart Foundation (Dr. Dekker Grant 2016T086), a personal VIDI grant from ZonMw/NWO (91717337) and a grant for the CORONIS project from ZonMW and the Dutch Heart Foundation. She served as a consultant to Biogen without payment. H.B. van der Worp served as a consultant to Bayer and LivaNova, with fees paid to his institution. Annemijn M. Algra is supported by a personal grant from the Dutch Heart Foundation (Dr. Dekker Grant 2016T023).

Funding Statement

CAPACITY-COVID is funded by the Dutch and British Heart Foundation, the EuroQol Research Foundation, Novartis Global, Amgen Europe, Novo Nordisk Nederland, Servier Nederland and Daiichi Sankyo Nederland.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

On the 17th of march 2020, the Medical Research Ethics Committee of the University Medical Center Utrecht, confirmed that the Medical Research Involving Human Subjects Act (WMO) does not apply to the above mentioned study. (Reference number WAG/avd/20/010579) and has exempted it for further approval.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Twitter: @woutersluis; @annemijn_algra;

Data Availability

The data used for this study, including de-identified individual participant data and a data dictionary defining each field or variable within the dataset, can be made available upon reasonable request to the data access committee of CAPACITY-COVID. These data will be made available following publication of this work. A data sharing agreement must be signed before any data are shared.

  • Abbreviations

    COVID-19
    Coronavirus disease 2019
    ICU
    Intensive Care Unit
    PCR
    Polymerase chain reaction
    PE
    Pulmonary embolism
    AF
    Atrial fibrillation
    TIA
    Transient ischemic attack
    NIHSS
    National Institutes of Health Stroke Scale
    IVT
    Intravenous thrombolysis
    EVT
    Endovascular therapy
    TOAST
    Trial of Org 10172 in Acute Stroke Treatment
    mRS
    Modified Rankin scale
    IQR
    Interquartile range
    SD
    Standard deviation
    CI
    Confidence interval
    RR
    Risk ratio
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted March 12, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Risk, clinical course and outcome of ischemic stroke in patients hospitalized with COVID-19: a multicenter cohort study
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Risk, clinical course and outcome of ischemic stroke in patients hospitalized with COVID-19: a multicenter cohort study
    Wouter M. Sluis, Marijke Linschoten, Julie E. Buijs, J. Matthijs Biesbroek, Heleen M. den Hertog, Tessa Ribbers, Dennis Nieuwkamp, Reinier C. van Houwelingen, Andreas Dias, Ingeborg W.M. van Uden, Joost P. Kerklaan, H. Paul Bienfait, Sarah E. Vermeer, Sonja W. de Jong, Mariam Ali, Marieke J.H. Wermer, Marieke T. de Graaf, Paul J.A.M. Brouwers, Folkert W. Asselbergs, L. Jaap Kappelle, H. Bart van der Worp, Annemijn M. Algra
    medRxiv 2021.03.11.21253189; doi: https://doi.org/10.1101/2021.03.11.21253189
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Risk, clinical course and outcome of ischemic stroke in patients hospitalized with COVID-19: a multicenter cohort study
    Wouter M. Sluis, Marijke Linschoten, Julie E. Buijs, J. Matthijs Biesbroek, Heleen M. den Hertog, Tessa Ribbers, Dennis Nieuwkamp, Reinier C. van Houwelingen, Andreas Dias, Ingeborg W.M. van Uden, Joost P. Kerklaan, H. Paul Bienfait, Sarah E. Vermeer, Sonja W. de Jong, Mariam Ali, Marieke J.H. Wermer, Marieke T. de Graaf, Paul J.A.M. Brouwers, Folkert W. Asselbergs, L. Jaap Kappelle, H. Bart van der Worp, Annemijn M. Algra
    medRxiv 2021.03.11.21253189; doi: https://doi.org/10.1101/2021.03.11.21253189

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (76)
    • Allergy and Immunology (198)
    • Anesthesia (54)
    • Cardiovascular Medicine (492)
    • Dentistry and Oral Medicine (90)
    • Dermatology (57)
    • Emergency Medicine (169)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (213)
    • Epidemiology (5714)
    • Forensic Medicine (3)
    • Gastroenterology (217)
    • Genetic and Genomic Medicine (871)
    • Geriatric Medicine (88)
    • Health Economics (232)
    • Health Informatics (765)
    • Health Policy (395)
    • Health Systems and Quality Improvement (254)
    • Hematology (105)
    • HIV/AIDS (184)
    • Infectious Diseases (except HIV/AIDS) (6511)
    • Intensive Care and Critical Care Medicine (393)
    • Medical Education (118)
    • Medical Ethics (28)
    • Nephrology (93)
    • Neurology (851)
    • Nursing (44)
    • Nutrition (142)
    • Obstetrics and Gynecology (163)
    • Occupational and Environmental Health (263)
    • Oncology (515)
    • Ophthalmology (164)
    • Orthopedics (44)
    • Otolaryngology (107)
    • Pain Medicine (48)
    • Palliative Medicine (21)
    • Pathology (149)
    • Pediatrics (251)
    • Pharmacology and Therapeutics (147)
    • Primary Care Research (114)
    • Psychiatry and Clinical Psychology (976)
    • Public and Global Health (2241)
    • Radiology and Imaging (377)
    • Rehabilitation Medicine and Physical Therapy (174)
    • Respiratory Medicine (313)
    • Rheumatology (109)
    • Sexual and Reproductive Health (81)
    • Sports Medicine (82)
    • Surgery (118)
    • Toxicology (25)
    • Transplantation (34)
    • Urology (42)